← Back to Search

Speech Entrainment for Aphasia

N/A
Recruiting
Led By Marja-Liisa Mailend, PhD
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 18-80 years at the time of enrollment
English as native language
Must not have
History of other comorbid neurological impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day post treatment
Awards & highlights

Summary

This trial looks at how speech entrainment can help people speak more efficiently and effectively. It tracks informativeness and efficiency of speech to measure outcomes.

Who is the study for?
This trial is for English-speaking adults aged 18-80 with aphasia, which affects their ability to communicate. They must be more than six months post-onset and have a specific score on the Western Aphasia Battery - Revised test. Participants need to commit to multiple sessions either at the testing site or at home.
What is being tested?
The study tests two types of speech entrainment practices: audiovisual and auditory, to improve independent speech in people with aphasia. It measures how informative and efficient their speech is after treatment when telling stories.
What are the potential side effects?
Since this trial involves practice-based interventions rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.
Select...
English is my first language.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of neurological problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and one day post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Correct Information Units per Minute
Secondary study objectives
Number of Different Words per Minute

Trial Design

2Treatment groups
Experimental Treatment
Group I: Auditory Speech Entrainment PracticeExperimental Treatment2 Interventions
Auditory Speech Entrainment includes repeated practice of speaking synchronously with a recorded model, which provides contextual, temporal, and auditory cues for speaking.
Group II: Audiovisual Speech Entrainment PracticeExperimental Treatment2 Interventions
Audiovisual Speech Entrainment includes repeated practice of speaking synchronously with a recorded model, which provides contextual, temporal, and audiovisual cues for speaking.

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
348 Previous Clinical Trials
180,697 Total Patients Enrolled
38 Trials studying Aphasia
2,526 Patients Enrolled for Aphasia
Albert Einstein Healthcare NetworkLead Sponsor
64 Previous Clinical Trials
868,669 Total Patients Enrolled
2 Trials studying Aphasia
107 Patients Enrolled for Aphasia
Marja-Liisa Mailend, PhDPrincipal InvestigatorAlbert Einstein Healthcare Network

Media Library

Audiovisual Speech Entrainment Practice Clinical Trial Eligibility Overview. Trial Name: NCT05687994 — N/A
Aphasia Research Study Groups: Auditory Speech Entrainment Practice, Audiovisual Speech Entrainment Practice
Aphasia Clinical Trial 2023: Audiovisual Speech Entrainment Practice Highlights & Side Effects. Trial Name: NCT05687994 — N/A
Audiovisual Speech Entrainment Practice 2023 Treatment Timeline for Medical Study. Trial Name: NCT05687994 — N/A
~4 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top